Losing your sense of smell can be one of the earliest warnings of brain disease

The sense of smell is one of the least examined of the human senses, easy to take for granted until a morning arrives when the coffee has no aroma and a favorite meal tastes flat. For most people a fading nose is a passing nuisance tied to a cold, allergies, or age. But a substantial body of neuroscience now treats a persistent, unexplained loss of smell as something more consequential: one of the earliest detectable signals that a degenerative disease may be taking hold in the brain, sometimes years before any of the symptoms usually associated with those conditions appear.

The reason lies in geography. The machinery that lets a person detect odor sits at the very front line between the outside world and the brain, and several of the diseases that erode memory and movement appear to begin their damage in precisely that region. That overlap turns the nose into an unlikely early-warning system, and researchers have spent decades working out how reliable a signal it actually is.

How the olfactory system works

Smell begins with specialized nerve cells in the olfactory epithelium, a patch of tissue high inside the nasal cavity. These neurons pass signals through openings in the skull to the olfactory bulbs, paired structures that serve as the first processing centers for scent before relaying information deeper into the brain. Because that pathway is exposed to the environment as a direct entry point to the brain, it is unusually vulnerable to damage from viruses, pollution, and injury. The spectrum of loss ranges from a reduced sense of smell, known as hyposmia, to its complete absence, called anosmia. Since flavor depends heavily on smell, people who lose the sense often report that food tastes muted even when their taste buds still register basic sweet, salty, sour, and bitter sensations.

Why the olfactory bulb is an early casualty

The link to brain disease turns on where the damage starts. According to the American Academy of Neurology’s Brain & Life, the misfolded proteins central to two of the most common neurodegenerative disorders accumulate first in the olfactory bulb, before other symptoms are detectable. In Parkinson’s disease the protein is alpha-synuclein; in Alzheimer’s disease it is amyloid-beta and tau. Because these deposits appear to interfere with normal smell processing at an early stage, an eroding sense of smell can act as a visible surface sign of a disease process already underway in tissue that no scan routinely checks. Specialists caution that this makes smell loss a marker rather than a cause, and one that has many innocent explanations, but its timing is what makes it valuable.

What the research shows about Parkinson’s and Alzheimer’s

The strength of the association is most striking in Parkinson’s disease. Neurologists estimate that between 75 and 95 percent of people with Parkinson’s have an impaired sense of smell, a deficit that can develop several years before the classic motor symptoms such as tremor and slowed movement appear. A peer-reviewed review of olfactory function and cognitive impairment, indexed at the National Institutes of Health, describes olfactory dysfunction as a common and early feature of both Parkinson’s and Alzheimer’s disease, reflecting pathology in the olfactory system that precedes typical clinical signs. Studies have also linked low scores on standardized smell tests to later cognitive decline and a higher probability of an Alzheimer’s diagnosis in the following years, which is why some memory clinics now include a scratch-and-sniff style identification test in their assessments.

Smell loss across related disorders

The pattern extends beyond the two best-known diseases. Reduced smell is also a recognized non-motor feature of Lewy body dementia, where olfactory loss frequently precedes the cognitive and movement changes that lead to diagnosis. Because Lewy body dementia, Parkinson’s, and related conditions share the same underlying protein biology, with alpha-synuclein accumulating in vulnerable brain tissue, the involvement of the olfactory system across all of them reinforces the idea that the nose is reporting on a common disease mechanism rather than a coincidence. That shared pathway is a central reason researchers view early smell testing as potentially useful across a family of disorders rather than a single one.

Why most smell loss is not a brain-disease alarm

The important caveat is that a diminished sense of smell is common and usually benign. Ordinary aging thins the olfactory tissue and narrows the bony openings the nerves pass through, so some decline is expected over a lifetime. Respiratory infections are a frequent cause, and certain viruses can strip smell temporarily or, in a minority of cases, permanently. Head trauma, chronic sinus disease, smoking, and some medications can all blunt the sense as well. What draws clinical attention is a smell loss that is unexplained, persistent, and not tied to an obvious cause such as a recent cold, particularly when it appears alongside other subtle changes. In those cases specialists may recommend follow-up rather than immediate alarm, since the sign is one piece of a larger picture.

Understood in context, the message is neither that a stuffy nose signals impending dementia nor that smell loss should be dismissed. It is that a sense long treated as trivial carries genuine diagnostic information, and that the tissue responsible sits close enough to the brain to register the first stirrings of disease. As research into early detection advances, that quiet signal from the nose may become a more routine part of catching neurodegenerative conditions at a stage when intervention has the best chance of mattering.

This article was produced with AI assistance and reviewed by Morning Overview editors.

More from Morning Overview